News
In his new role, Chen will enhance shareholder value and guide Harbour BioMed through its next phase of strategic development ...
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback